Posted in | News | Nanomaterials

Desmet Ballestra Enters Sales Agreement for Cavitation Technologies’ Nano Reactor System

Cavitation Technologies, Inc. (CVAT) Berlin: (Stuttgart:WTC) announced today that the Desmet Ballestra Group, CTi's strategic partner since 2010 and licensee of the company's vegetable oil refining technology, has entered into a sales agreement with a soybean oil refinery in North America. This newly built refinery will process approximately 500 tons of soybean oil and Desmet projects that system will be fully installed and operational in 2015.

CTi anticipates approximately $350,000 in revenue from this sale to be received in the 2nd and 3rd fiscal quarters of 2015. With multiple installations in North and South America, this new order marks CTi's 12th system sale in a region that was the strongest for company's line of products in edible oil processing and refining.

President Igor Gorodnitsky comments, "We are excited to have our first system sale in fiscal 2015. We believe that fiscal 2015 will encompass a combination of the benefits our technology brings in vegetable oil refining, production of ethanol and biodiesel, water and petroleum treatment. Our invaluable relationships with our licensees, the Desmet Ballestra Group and GEA Westfalia provide our company with very strong business partnership with global technology leaders."

About CTI

Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, robust devices and systems and develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement and water treatment. As an add-on to existing neutralization systems, the company's patented Nano-Reactor® allows refiners to significantly reduce both processing costs and the environmental impact, while also increasing the yield. More information is available at http://www.ctinanotech.com/.

About Desmet Ballestra Group

The Desmet Ballestra Group is a world leader in the fields of engineering and supply of plants and equipment for the oils, fats, animal feed industries, detergents, surfactants and related chemical industries and the oleo-chemical and biodiesel industries. Desmet Ballestra possesses a great worldwide reputation, thanks to over 60 years of experience, a significant R&D capacity and the most extensive customer base in the industry. The company has sales and engineering offices in 15 countries. In May 2011, the Company signed a three-year licensing agreement with Desmet and since then Desmet has marketed and installed CTi's Nano-Reactor® systems in edible vegetable oil refineries around the world. In May of 2012, CTi signed a global R&D, Marketing and Technology License Agreement with Desmet, which gives CTi the flexibility to pursue new research and applications while Desmet, markets CTi's technology to major clients around the world. More information is available at http://www.desmetballestra.com/ .

About GEA Westfalia Separator Group

GEA Westfalia is a leading worldwide developer of procedures and processes for the mechanical clarification and separation of liquids for agricultural industries, as well as the renewable energy, chemical, pharmaceutical, biotechnology, petroleum, shipping, marine, environmental, dairy, and beverage industries. GEA Westfalia's global network encompasses more than 50 sales and service centers worldwide, 12,000 employees, and annual sales exceeding $7 Billion. In August of 2012, CTi entered into a Technology and Licensing Agreement with GEA Westfalia.

Source: http://www.ctinanotech.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.